Angle PLC Announces Exclusive agreement for DNA NGS panel
ANGLE ANNOUNCES NEXT GENERATION SEQUENCING ASSAY AGREEMENT WITH NUPROBE Option for exclusive licence to highly sensitive NGS assay for use with CTCs and dual analysis of CTCs with ctDNA Combining the Parsortix system with comprehensive DNA molecular analysis opens up a broad range of pharma services opportunities GUILDFORD, SURREY / ACCESSWIRE / September 23, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is delighted to announce that it has signed an agreement with the cutting-edge genomics and molecular diagnostics company, NuProbe USA, Inc. ("NuProbe"), to use its proprietary pan-cancer next generation sequencing (NGS) panel ("the NGS panel"). Under the terms of the agreement, NuProbe has granted the Company an option for an exclusive global license to the NGS panel outside of China for the analysis of CTCs and the dual analysis of CTCs and ctDNA.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - Sept 20
Purchase of own shares LONDON, UK / ACCESSWIRE / September 20, 2024 / The Company announces that on 19 September 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - Sept 19
Purchase of own shares LONDON, UK / ACCESSWIRE / September 19, 2024 / The Company announces that on 18 September 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Angle PLC Announces Agreement with Recursion Pharmaceuticals
New pharma agreement for Parsortix CTC analysis GUILDFORD, SURREY / ACCESSWIRE / September 19, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce that it has signed an agreement with Recursion Pharmaceuticals, Inc. ("Recursion"), a leading clinical stage TechBio company decoding biology to radically improve lives. The agreement is being initiated with a fully funded pilot study.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - Sept 18
Purchase of own shares LONDON, UK / ACCESSWIRE / September 18, 2024 / InterContinental Hotels Group PLC (the Company) The Company announces that on 17 September 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - Sept 17
Purchase of own shares LONDON, UK / ACCESSWIRE / September 17, 2024 / The Company announces that on 16 September 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Angle PLC Announces Notice of Interim Results and Webcast
Notice of Interim Results and Webcast GUILDFORD, SURREY / ACCESSWIRE / September 17, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, will be releasing its interim results for the six months ended 30 June 2024 on Thursday 26 September 2024. A meeting for analysts will be held at 11:00 am BST on Thursday 26 September 2024 at the offices of Berenberg, 60 Threadneedle Street, London EC2R 8HP.
Warpaint London PLC Announces Interim Results
Interim Results for the six months ended 30 June 2024 Significant growth in sales, margins and profit to achieve another record first half LONDON, UNITED KINGDOM / ACCESSWIRE / September 17, 2024 / Warpaint London plc ("Warpaint", the "Company" or the "Group") (AIM:W7L)(OTCQX:WPNTF), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands is pleased to announce its unaudited interim results for the six months ended 30 June 2024 ("H1"). Unaudited six months to 30 June 2024 Unaudited six months to 30 June 2023 Growth Revenue £ 45.8m £ 36.7m +25 % Gross profit margin 42.5 % 39.1 % +334bps EBITDA £ 12.0m £ 7.3m +66 % Adjusted EBITDA* £ 11.4m £ 7.9m +44 % Profit from operations £ 11.0m £ 6.3m +75 % Basic earnings per share (EPS) 10.37p 6.22p +67 % Highlights Strong growth in sales during the period, particularly in the UK and Europe, achieving a record first half Group sales increased by 25% to £45.8 million in H1 2024 (H1 2023: £36.7 million) UK revenue increased by 17% to £15.5 million (H1 2023: £13.3 million) International revenue increased by 30% to £30.3 million (H1 2023: £23.4 million) W7 sales increased by 25% and Technic sales increased by 34% Gross profit margin increased by a further 334 bps to 42.5% (H1 2023: 39.1%), primarily due to successful launches of new product lines, sourcing and volume savings, growing e-commerce revenue and increased US profitability Adjusted EBITDA* grew 44% to £11.4 million (H1 2023: £7.9 million) Profit from operations was up 75% to £11.0 million (H1 2023: £6.3 million) Cash of £5.5 million as at 30 June 2024 (30 June 2023: £7.1 million), reflecting the increase in stock and corporation tax paid on account in H1 and no debt.
Flutter Entertainment PLC Announces Acquisition of Snaitech
Addition of Snai enhances Flutter's gold medal position in attractive Italian market DUBLIN & TORONTO, ON / ACCESSWIRE / September 17, 2024 / Flutter Entertainment (NYSE:FLUT)(LSE:FLTR) ("Flutter")the world's leading online sports betting and iGaming operatortoday announces that it has agreed to acquire Snaitech S.p.A. ("Snai"), one of Italy's leading omni-channel operators, from a subsidiary of Playtech plc, for cash consideration based on an enterprise value of €2.3b1.
i3 Energy PLC Announces Interview in relation to Gran Tierra transaction
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATION OF SUCH JURISDICTION Proactive Investors interview in relation to Gran Tierra transaction EASTLEIGH / ACCESSWIRE / September 16, 2024 / I3 Energy plc ("i3 Energy" or the "Company") (AIM:I3E)(TSX:ITE)(FRA:I32) Majid Shafiq, CEO of i3 Energy, has conducted an interview with Proactive Investors in relation to the recommended and final cash and share acquisition of the entire issued, and to be issued, share capital of i3 Energy by Gran Tierra Energy Inc. ("Gran Tierra") as announced on 19 August 2024. The Proactive Investors interview can be found here Click Here and is also available on the Company's website at Click Here
InterContinental Hotels Group PLC Announces Transaction in Own Shares - Sept 16
Purchase of own shares LONDON, UNITED KINGDOM / ACCESSWIRE / September 16, 2024 / The Company announces that on 13 September 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Gold hits a new all-time high, setting mining stocks alight
Mining stocks have pulled ahead after gold prices hit a record high of US$2,568 (£1,957) per ounce. Fresnillo PLC (LSE:FRES) is up 2.5%, Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF) is up 2.1%, Glencore PLC (LSE:GLEN) 1.4% and Antofagasta plc 1.3%.
